| 今开：6.58 | 昨收：6.48 |
| 最高：6.965 | 最低：6.51 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.093625006E9 |
Ironwood医药(IRWD)04-26 04:35
$Ironwood医药(IRWD)$ ARS Annual Report to Security Holders Accession Number: 0001104659-24-052002 Act: 34 Size: 1 MB 网页链接查看全文
Ironwood医药(IRWD)04-26 04:35
$Ironwood医药(IRWD)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-051995 Act: 34 Size: 402 KB 网页链接查看全文
Ironwood医药(IRWD)05-23 04:15
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-063480 Size: 4 KB 网页链接查看全文
Ironwood医药(IRWD)05-18 04:15
$Ironwood医药(IRWD)$ 144 Report of proposed sale of securities Accession Number: 0001932525-24-000001 Act: 33 Size: 5 KB 网页链接查看全文
Ironwood医药(IRWD)05-18 04:15
$Ironwood医药(IRWD)$ 144 Report of proposed sale of securities Accession Number: 0001875067-24-000002 Act: 33 Size: 4 KB 网页链接查看全文
Ironwood医药(IRWD)06-11 05:05
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-071393 Size: 6 KB 网页链接查看全文
Ironwood医药(IRWD)06-22 04:15
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076213 Size: 4 KB 网页链接查看全文
Ironwood医药(IRWD)04-26 04:35
$Ironwood医药(IRWD)$ DEF 14A Other definitive proxy statements Accession Number: 0001104659-24-051992 Act: 34 Size: 6 MB 网页链接查看全文
Ironwood医药(IRWD)06-22 04:15
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076207 Size: 4 KB 网页链接查看全文
Ironwood医药(IRWD)06-22 04:15
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076216 Size: 7 KB 网页链接查看全文
淡投2013-01-15 07:28
$Ironwood医药(IRWD)$ has completed the offering of $175 million Linaclotide PhaRMA 11% notes. Ironwood Pharma intends to use the funds from the transaction to support the commercial launch of its lead product Linzess. The net proceeds will also be used to fund its research an...查看全文
北京时间2024年03月01日22时33分，Ironwood医药（IRWD.us）股票出现波动，股价快速下跌5.30%。截至发稿，该股报8.93美元/股，成交量22.3439万股，换手率0.14%，振幅4.03%。 最近的财报数据显示，该股实现营业... 网页链接
智通财经APP获悉，美国食品和药物管理局(FDA)扩大了对Ironwood医药(IRWD.US)药物Linzess的批准，将其纳入儿童和青少年功能性便秘的治疗范围。 目前，Linzess已经被批准用于治疗患有便秘或特发性便秘的成人肠易激综合征。该药物由Ironwoo... 网页链接
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076206 Size: 4 KB 网页链接
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076216 Size: 7 KB 网页链接
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076207 Size: 4 KB 网页链接
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076210 Size: 4 KB 网页链接
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076220 Size: 4 KB 网页链接
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076209 Size: 4 KB 网页链接
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076211 Size: 5 KB 网页链接
$Ironwood医药(IRWD)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-076213 Size: 4 KB 网页链接
$Ironwood医药(IRWD)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-073736 Act: 34 Size: 212 KB 网页链接
$Ironwood医药(IRWD)$ 8-K Current report, items 5.02 and 8.01 Accession Number: 0001104659-24-073391 Act: 34 Size: 203 KB 网页链接